The Policy, Politics & Law of Cancer
Roy Herbst, MD, PhD, on Legal and Policy Issues Associated With Cutting-Edge Cancer Treatments
Roy Herbst, MD, PhD, Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital, speaks during Panel 5: Legal and Policy Issues Associated With Cutting-Edge Cancer Treatments at The Poli...
Barbara McAneny, MD, on The Business of Cancer
Barbara McAneny, MD, Co-Founder and CEO, New Mexico Oncology Hematology Consultants; President-Elect, American Medical Association, speaks during Panel 2: The Business of Cancer at The Policy, Politic...
Norman Sharpless, MD: Keynote Address
Norman Sharpless, MD, Director, National Cancer Institute, presents the Keynote Address at The Policy, Politics and Law of Cancer, presented by The Solomon Center for Health Law and Policy at Yale Law...
Siddhartha Mukherjee, MD, DPhil: Keynote Address
Siddhartha Mukherjee, MD, DPhil, Assistant Professor of Medicine, Columbia University Medical Center, presents the Keynote Address at The Policy, Politics and Law of Cancer, presented by The Solomon C...
Charles Sawyers, MD, on Legal and Policy Issues Associated With Cutting-Edge Cancer Treatments
Charles Sawyers, MD, Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, speaks during Panel 5: Legal and Policy Issues Associated With Cutting-Edge Cancer Treatmen...
Peter Bach, MD, MAPP, on Drug Development and the Cost of Researching and Treating Cancer
Peter Bach, MD, MAPP, Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, speaks during Panel 4: Drug Development and the Cost of Researching and Treating Ca...
Amy Kapczynski, JD, on Drug Development and the Cost of Researching and Treating Cancer
Amy Kapczynski, JD, Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School, speaks during Panel 4: Drug Development and the Cost of Researching and Treating Cancer a...
Jeffrey Schwartz, MBA, on Drug Development and the Cost of Researching and Treating Cancer
Jeffrey Schwartz, MBA, Managing Director, Bain Capital Life Sciences, speaks during Panel 4: Drug Development and the Cost of Researching and Treating Cancer at The Policy, Politics and Law of Cancer,...
Levi Garraway, MD, PhD, on Drug Development and the Cost of Researching and Treating Cancer
Levi Garraway, MD, PhD, Senior Vice President, Global Development & Medical Affairs, Eli Lilly, speaks during Panel 4: Drug Development and the Cost of Researching and Treating Cancer at The Polic...
Deborah Schrag, MD, MPH, on Cancer, Health Justice, and Disparities
Deborah Schrag, MD, MPH, Chief, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School, speaks during Panel 3: Can...
Blase Polite, MD, on Cancer, Health Justice, and Disparities
Blase Polite, MD, Associate Professor of Medicine, University of Chicago Medical Center, speaks during Panel 3: Cancer, Health Justice, and Disparities at The Policy, Politics and Law of Cancer, prese...
Otis Brawley, MD, on Cancer, Health Justice, and Disparities
Otis Brawley, MD, Chief Medical Officer, American Cancer Society, speaks during Panel 3: Cancer, Health Justice, and Disparities at The Policy, Politics and Law of Cancer, presented by The Solomon Cen...
Lee Newcomer, MD, MHA, on The Business of Cancer
Lee Newcomer, MD, MHA, Senior Vice President, Oncology, Genetics and Women’s Health, UnitedHealthcare, speaks during Panel 2: The Business of Cancer at The Policy, Politics and Law of Cancer, presente...
Randall Oyer, MD, on The Business of Cancer
Randall Oyer, MD, Medical Director, Oncology Program, Lancaster General Hospital, speaks during Panel 2: The Business of Cancer at The Policy, Politics and Law of Cancer, presented by The Solomon Cent...
Ed Benz, MD, on The Business of Cancer
Ed Benz, MD, President and CEO Emeritus, Dana-Farber Cancer Institute, speaks during Panel 2: The Business of Cancer at The Policy, Politics and Law of Cancer, presented by The Solomon Center for Heal...
Abe Lopman, MBA, on The Business of Cancer
Abe Lopman, MBA, Senior Vice President, Operations; Executive Director, Smilow Cancer Hospital at Yale New Haven, speaks during Panel 2: The Business of Cancer at The Policy, Politics and Law of Cance...
Richard Schilsky, MD: Is the Federal Government a Productive Partner in Cancer Policy?
Richard Schilsky, MD, Chief Medical Officer, ASCO, speaks during Panel 1: Is the Federal Government a Productive Partner in Cancer Policy? at The Policy, Politics and Law of Cancer, presented by The S...
Nancy Goodman, JD, MPP: Is the Federal Government a Productive Partner in Cancer Policy?
Nancy Goodman, JD, MPP, Executive Director, Kids V Cancer, speaks during Panel 1: Is the Federal Government a Productive Partner in Cancer Policy? at The Policy, Politics and Law of Cancer, presented ...
Nancy Goodman, JD, MPP: Is the Federal Government a Productive Partner in Cancer Policy?
Nancy Goodman, JD, MPP, Executive Director, Kids V Cancer, speaks during Panel 1: Is the Federal Government a Productive Partner in Cancer Policy? at The Policy, Politics and Law of Cancer, presented ...
Nancy Goodman, JD, MPP: Is the Federal Government a Productive Partner in Cancer Policy?
Nancy Goodman, JD, MPP, Executive Director, Kids V Cancer, speaks during Panel 1: Is the Federal Government a Productive Partner in Cancer Policy? at The Policy, Politics and Law of Cancer, presented ...
